Business Context and Reporting Period
This Form 8-K Current Report was filed by Genius Brands International, Inc. (trading symbol: GNUS) on July 22, 2019. The filing reports the entry into a Material Definitive Agreement involving the company's debt and equity holders.
Key Financial Metrics and Agreements
The filing details a restructuring of the company's 10% Secured Convertible Notes due August 20, 2019, and related equity agreements. Key terms include:
- Conversion Price Reduction: The conversion price of the Notes was reduced from $2.50 per share to $1.515 per share.
- Waiver Warrants Issued: The company agreed to issue warrants to purchase up to 1,800,000 shares of Common Stock.
- Warrant Terms: The warrants have an exercise price of $1.14 per share, become exercisable six months and one day after issuance, and expire five years after issuance.
- Consent for Offering: Holders consented to a proposed public offering (the "Offering") with an effective per share purchase price of less than $2.50.
The filing text does not provide specific values for revenue, profit, cash flow, margins, total debt, or liquidity positions.
Material Changes
The primary material change is the amendment to the August 2018 and January 2018 Purchase Agreements. This amendment redefines "Exempt Issuance" to allow for the proposed Offering and waives certain rights and remedies held by the note and stockholders. In exchange for these waivers and consents, the company provided the conversion price reduction and the new warrant issuance.
Guidance, Outlook, and Risks
The filing indicates the company is proceeding with a public offering of common stock at a price below $2.50 per share, subject to the waivers obtained. No specific financial guidance, revenue outlook, or management commentary regarding future performance is included in this document. The filing notes that the summaries of the agreements are subject to the full text of the attached exhibits.
Investor Verification Checklist
- Verify the full terms of the "Amendment, Waiver and Consent Agreement" in Exhibit 10.1.
- Review the specific terms of the "Waiver Warrants" in Exhibit 4.2, including vesting schedules and expiration.
- Confirm the status and pricing of the proposed public offering mentioned in the consent.
- Assess the dilution impact of the 1,800,000 new warrants and the reduced conversion price on existing shareholders.
- Check subsequent filings for the actual execution of the proposed Offering.